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Abstract 
Coffee, a complex brew containing hundreds of biologically active compounds, exerts 
potent effects on long-term human health. Recently, a plethora of studies have been 
published focusing on health outcomes associated with coffee intake. An inverse 
association between coffee consumption and all-cause mortality has been seen 
consistently in large prospective studies. Habitual coffee consumption is also associated 
with lower risks for cardiovascular (CV) death and a variety of adverse CV outcomes, 
including coronary heart disease (CHD), congestive heart failure (HF), and stroke; 
coffee’s effects on arrhythmias and hypertension are neutral. Coffee consumption is 
associated with improvements in some CV risk factors, including type 2 diabetes (T2D), 
depression, and obesity. Chronic coffee consumption also appears to protect against 
some neurodegenerative diseases, and is associated with improved asthma control, 
and lower risks for liver disease and cancer. Habitual intake of 3 to 4 cups of coffee 
appears to be safe and is associated with the most robust beneficial effects. However, 
most of the studies regarding coffee’s health effects are based on observational data, 
with very few randomized controlled trials. Furthermore, the possible benefits of coffee 
drinking must be weighed against potential risks, which are generally due to its high 
caffeine content, including anxiety, insomnia, headaches, tremulousness, and 
palpitations. Coffee may also increase risk of fracture in women, and when consumed in 
pregnancy coffee increases risk for low birth weight and preterm labor.  
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Introduction 
American adults drink more coffee than any other beverage except water (Fig 1).1   
Coffee is the major source of caffeine intake for adults, though the profound and 
multifaceted biological effects of chronic coffee intake go far beyond the actions of 
caffeine. Consumption of coffee has been generally rising for the past 25 years, and 
today about 2 out of every 3 American adults drink coffee on a daily basis.2 The 
population in the United States (US) consumes over 400 million cups of coffee daily, 
and has the highest per capita coffee intake of any nation.3  Because of its widespread 
habitual consumption even modest health effects of coffee will likely have important 
public health implications. The purpose of this review is to summarize the emerging 
data regarding the effects of habitual coffee consumption on long-term health and 
wellbeing, focusing especially on cardiovascular (CV) health.  
 
Bioactive Compounds in Coffee 
 
Coffee is a complex brew containing over 1,000 botanical compounds, many of which 
are biologically active, including caffeine (a central nervous system stimulant and 
bronchodilator), diterpenes (which can increase serum cholesterol), chlorogenic acid 
(which improves glucose metabolism), as well as melanoids, quinides, lignans, and 
trigonelline—all of which confer antioxidant and anti-inflammatory effects.4  
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Caffeine is largely responsible for the intrinsically habit-forming nature of coffee. 
The caffeine content of coffee is highly variable, even when the coffee beverage is 
obtained from the same vendor.3,5 A typical 8-ounce cup of brewed coffee contains from 
70 to 165 mg of caffeine. Yet, in the US serving sizes of coffee are often much larger 
(commonly 10 to 24 ounces), often delivering 180 to 300 mg of caffeine per serving.3,6 
Instant coffee contains approximately 30 to 90 mg of caffeine per cup, whereas 
espresso usually has about 60 mg per shot.   Brewed decaffeinated coffee contains only 
about 3 mg of caffeine per 8 ounces.  
 
Coffee’s Effects on Blood Pressure, Coronary Calcium, Erectile Function and 
Obesity  
 
Coffee drinking can acutely cause modest increases in blood pressure (BP) among 
caffeine-naive individuals but exerts insignificant effects on BP levels on habitual coffee 
drinkers.7 Meta-analyses consistently report that coffee does not cause clinically 
important changes in BP, nor does it increase the risk of hypertension (HTN).7,8 The 
Nurses’ Health Study based on 1.4 million person-years of follow-up found that coffee 
consumption (up to 6 cups/day) was not associated with an increased risk of developing 
HTN.9  However, coffee is high in caffeine, which is metabolized by the cytochrome 
P450 1A2 (CYP1A2) enzyme. People who are homozygous for the CYP1A2*1A allele 
metabolize caffeine rapidly, whereas individuals who carry the variant CYP1A2*1F allele 
tend to be relatively slow at metabolizing caffeine.  Cross sectional studies suggest that 
slow caffeine metabolizers may be at higher risk for developing HTN and myocardial 
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infarction. 10,11  
 
Among 3,724 males over the age of 20 who participated in the National Health 
and Nutrition Examination Survey, the men who consumed the amount of caffeine 
present in about 2 or 3 cups of coffee daily had a 42% lower occurrence of erectile 
dysfunction.12 
 
Epidemiological studies indicate that coffee consumption may reduce the 
likelihood of developing obesity. Especially among individuals who are genetically 
predisposed to develop obesity, higher coffee consumption is associated with lower 
body mass index.13 In other words, habitual coffee consumption might attenuate a 
genetic tendency to become obese.  
 
Coffee and Diabetes  
 
Although caffeine acutely increases both glucose and insulin levels in short term 
studies,14 coffee paradoxically reduces the risk of type 2 diabetes (T2D) in long-term 
studies. This is likely because coffee contains high concentrations of potent 
antioxidants, yet has no calories. Notably, intervention trials have established the fact 
that coffee consumption can improve glucose metabolism and insulin sensitivity. One 
16-week randomized trial found that both caffeinated coffee and decaffeinated coffee 
reduced post-glucose challenge blood sugar levels.15 Additionally, an 8-week 
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randomized placebo-controlled study showed that coffee improves levels of 
adiponectin—an insulin-sensitizing cytokine.14  
 
 
A large meta-analysis of prospective cohort studies show a clear inverse 
relationship between coffee consumption and the likelihood of developing T2D 
whereby every additional cup/day conferred an additional 7% risk reduction (Fig 
2).16,17  This study reported that compared to non-coffee drinkers, subjects who 
consumed 6 or more cups of coffee daily had a significantly lower risk of developing 
T2D (relative risk [RR]: 0.65; 95% CI: 0.54 to 0.78); subjects who consumed 4 to 6 cups 
daily also had a significantly lower risk of T2D (RR: 0.72; 95% CI: 0.62 to 0.83).17  
 
Recent studies show that changes in one’s habitual coffee consumption 
translate into subsequent changes in risk of T2D. By studying three large prospective 
cohorts with > 1.6 million person-years of follow-up, Ding and colleagues found that 
individuals who increased their consumption of coffee by one or more cups/day had an 
11% lower risk of developing T2D.18  Conversely, individuals who reduced their coffee 
intake by 1 cup/day increased their risk of developing T2D by 17%. Importantly, adding 
sugar or other sweeteners to coffee can diminish its potential benefits on glucose 
metabolism.19-21 
 
Landmark Epidemiology Studies 
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Recent large prospective cohort studies using rigorous statistical methodology have 
consistently found that habitual coffee consumption is associated with a host of health 
benefits. The cumulative body of data indicates that moderate coffee consumption, 
about 2 to 5 cups (16 to 40 ounces) daily, may be associated with lower all-cause 
mortality rates, and lower risks for CV death, T2D, liver disease, Parkinson’s disease, 
depression and suicide.  
 
 
Recently, Poole and colleagues analyzed the totality of higher level evidence 
regarding the effects of coffee consumption on all studied health outcomes.22 In the 
most comprehensive analysis of coffee’s health effects published thus far, the 
researchers concluded that drinking 3 to 4 cups of coffee daily conferred the maximal 
health benefits, including highly significant risk reductions in all-cause mortality (RR 
0.83, CI 0.78 to 0.88), CV mortality (RR 0.81, CI 0.72 to 0.90), and CV disease 
(RR0.85, CI 0.80 to 0.90). In this definitive umbrella review of meta-analyses, high 
versus low coffee intake was also associated with an 18% lower risk of cancer 
occurrence.22  Although there is some evidence that drinking more than 4 cups of coffee 
per day could have adverse effects in young people,23 the majority of evidence supports 
the efficacy and safety of moderate-high coffee doses. 
 
 
Higher coffee intake was associated with improved life expectancy and reduced 
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risk of CV mortality in EPIC—a multicenter prospective cohort study of 521,330 adults 
who were recruited from 10 European countries (Denmark, France, Germany, Greece, 
Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom) and followed 
for an average of 16 years.6  This study found that daily coffee drinkers had a 7% to 
12% lower risk of dying prematurely compared to non-drinkers; a daily intake of at least 
3 cups of coffee per day was associated with a significantly lower risk of all-cause 
mortality.  Moreover, participants who consumed at least 2 cups/day were less likely to 
die from suicide, and diseases of the circulatory and digestive systems.6   
 
Investigators incorporating machine learning in their analysis of data from the 
Framingham Heart Study recently reported that coffee consumption was associated 
with a reduced risk for major adverse CV events.24   Compared to no coffee, every 
8-ounce cup/day reduced the risk of heart failure (HF) by 7%, stroke by 8%, and 
coronary heart disease (CHD) by 5%. A different meta-analysis found a U-shaped 
association between coffee consumption and the occurrence of HF, wherein 4 cups/day 
of coffee was linked with the lowest risk.25  Importantly, caffeine intake at doses up to 
500 mg/day (equivalent to 4 or 5 cups of coffee) does not change the frequency, 
inducibility, or severity of ventricular arrhythmias, as shown in multiple randomized 
placebo-controlled trials.26,27  Furthermore, several large prospective epidemiological 
studies report that consumption of coffee with or without caffeine is not associated with 
a heightened risk of atrial fibrillation.28,29  
 
Another recent cohort study followed 19,896 middle-aged university graduates 
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from Spain.30  After statistically adjusting for potential confounders, drinking at least two 
cups of coffee per day was associated with a 22% lower risk of all-cause mortality, with 
a hazard ratio (HR) = 0.78; 95% confidence interval (CI) = 0.66-0.92. In this cohort the 
coffee protection was most significant among individuals at least 45-years-old, for whom 
drinking 2 additional cups of coffee per day was linked with a 30% lower risk of mortality 
during follow-up (adjusted HR = 0.70; 95% CI = 0.58-0.85).30  
 
Harvard researchers followed 208,000 health professionals for about 25 years as 
part of a prospective cohort study to assess coffee’s effects on survival.31 They reported 
significant inverse associations for both caffeinated (P value for trend < 0.001) and 
decaffeinated coffee (P value for trend = 0.022) and all-cause mortality (Fig 3).  
Additionally, coffee consumption was significantly inversely associated with CV 
mortality, and mortality due to neurologic disease.31 A meta-analysis of 36 prospective 
cohort studies with 1,279,804 participants found that moderate coffee consumption was 
associated with lower risks of adverse CV events.32 Coffee intake of 3 to 5 cups/day 
was associated with the lowest risk, with less benefit noted at lighter and heavier coffee 
intakes.32  
 
A very recent paper focused on a multi-ethnic prospective cohort study 
comprised of 185,000 non-white participants including African-Americans, Native 
Americans, Hawaiians, Japanese-Americans, and Latinos who were followed for a 
mean of 16 years.5 This study found that coffee intakes of 1 cup/day and 3 cups/day 
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were associated with 12% and 18% reductions in risk of all-cause mortality, respectively 
(Fig 4).5  This study reported that daily coffee consumption was also associated with 
reduced risks for death due to CV disease, cancer, T2D, respiratory disease and kidney 
disease.5 
 
Coffee consumption is significantly associated with improved asthma control, and 
reduced risk of some gastrointestinal diseases, including reduced risks for liver disease, 
hepatic steatosis, and liver cancer.22 A large meta-analysis comprised of 432,133 
participants suggested that increasing coffee consumption might substantially reduce 
the risk of cirrhosis in a dose–dependent fashion.33  An increase in coffee consumption 
of 2 cups/day was linked to a decrease risks for cirrhosis, RR = 0.58 (95% CI 0.41–
0.76), and for death from cirrhosis the RR = 0.55 (95% CI 0.35–0.74).  
 
Coffee and Brain Health 
 
The habitual consumption of coffee daily is also strongly associated with lower risks for 
neurodegenerative diseases, including Parkinson's disease and Alzheimer’s dementia. 
34,35 A meta-analysis of 26 studies reported that coffee intake of about 3 cups/day 
reduced the risk of developing Parkinson’s disease by 25% (Fig 5).36 Additionally, 
recent reviews concluded that moderate coffee consumption might reduce the risk for 
Alzheimer's disease, though the precise impact is not yet clear.34,35 Moreover, coffee 
intake is associated with lower risks for multiple sclerosis, depression and suicide.5 
Caffeinated coffee (but not decaffeinated coffee) produced a dose-dependent reduced 
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risk of depression and suicide in a group of 208,000 people followed at least 16 years.37 
Four cups of coffee/day reduced risk of suicide by about 50% in both men and women 
(Fig 6).  
 
 
Limitations  
 
The apparent health benefits of coffee are predominantly based on observational data, 
with a paucity of randomized controlled studies. Association does not prove causation; 
though the experimental data is generally confirmatory regarding the epidemiological 
findings suggesting coffee has beneficial effects on human health. Even so, larger long-
term randomized placebo controlled outcome studies with coffee are not feasible for 
many reasons.  
 
The potential benefits of daily coffee consumption must be balanced against 
potential risks.  The diterpenes in coffee can raise serum cholesterol.38 In particular, 
boiled unfiltered coffee can raise cholesterol modestly. However, a standard coffee filter 
removes diterpenes and thus filtered coffee has largely neutral effects on lipids.22 Other 
adverse effects are predominantly due to the high caffeine content of most coffee 
preparations, which can lead to insomnia, anxiety, palpitations, tremors, in addition to 
bone loss and the potential for increased fracture risk, especially among women.3 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
13 
 
Additionally, coffee and caffeine consumption during pregnancy can increase risk for 
low birth weight and preterm birth.22  
 
The International Agency for Research on Cancer (IARC), which is the cancer 
agency of the World Health Organization, recently classified the drinking of very hot 
beverages (hotter than 149 degrees Fahrenheit or 65 degrees Celsius) a 
probable carcinogen.39   Hot coffee is typically served at about 65 degrees Celsius, so 
coffee should be allowed to cool to less than scalding hot temperatures before drinking. 
Additionally, roasted coffee contains acrylamide, a potential carcinogen. However, the 
level of acrylamide in coffee is very low, and the IARC has recently concluded that 
coffee is associated with decreased risks for liver cancer and endometrial cancer, and is 
unlikely to cause breast cancer, prostate cancer, or pancreatic cancer.39  
 
Finally, regular coffee consumption leads to physical and psychological 
dependence—another consequence of its high caffeine content.  Yet, even this liability 
can be advantageous in that the predictable withdrawal symptoms of headache, fatigue 
and lethargy tend to reinforce daily coffee intake—which in fact is the single richest 
source of antioxidants in the American diet.3 
 
Conclusions 
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 An increasingly impressive and consistent body of data indicates that coffee 
consumption is associated with dose-dependent reductions in all-cause mortality and 
CV mortality. Coffee also reduces risks for T2D, liver disease, Parkinson’s disease, 
depression, and suicide. Daily consumption of 2 to 5 cups of coffee (16 to 40 ounces) 
with caffeine intakes up to 400 mg/day appears to be safe and is linked with the 
strongest beneficial effects for the majority of the studied health outcomes.  
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Figure Legend 
 
Figure 1:  Americans drink more coffee than soda, tea and juice combined. Karl Paul, 
reporter for MarketWatch:  International Coffee Day: Sept 29, 2017.1   
 
Figure 2: Dose-response analysis of the association between coffee consumption and 
risk of type 2 diabetes.16  
 
Figure 3:  Hazard ratio of mortality with coffee consumption (in cups/day).31  
 
Figure 4: Fully adjusted Cox all-cause mortality curves were generated using the Cox 
mode.  The “None” and “1 - 3 cups” lines overlap.5 
 
Figure 5: Coffee intake in cups per day and risk of developing Parkinson’s disease.36 
 
Figure 6: Coffee intake in cups per day and suicide risk.37  
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Figure 6  
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